Marshall Wace North America L.P. - SURFACE ONCOLOGY INC ownership

SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 93 filers reported holding SURFACE ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of SURFACE ONCOLOGY INC
ValueSharesWeighting
Q3 2021$286,000
-57.5%
37,784
-63.2%
0.00%
-75.0%
Q2 2020$673,000
+55.8%
102,565
+160.3%
0.00%
+300.0%
Q3 2018$432,00039,4000.00%
Other shareholders
SURFACE ONCOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 2,945,453$27,216,0004.31%
Atlas Venture Associates XI, LLC 2,945,453$27,216,0004.31%
ACUTA CAPITAL PARTNERS, LLC 999,500$9,235,0002.51%
COMMODORE CAPITAL LP 467,796$4,322,0002.35%
Ghost Tree Capital, LLC 1,000,000$9,240,0002.06%
VR Adviser, LLC 1,442,895$13,332,0001.96%
SILVERARC CAPITAL MANAGEMENT, LLC 130,000$1,201,0000.70%
Parkman Healthcare Partners LLC 175,792$1,624,0000.42%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 26,732$247,0000.39%
One68 Global Capital, LLC 15,071$139,0000.28%
View complete list of SURFACE ONCOLOGY INC shareholders